重庆药友制药有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
315
NMPA:315
Drug Approvals
Levodopa and Benserazide Hydrochloride Tablets
- Product Name
- 多巴丝肼片
- Approval Number
- 国药准字H20254523
- Approval Date
- Jun 10, 2025
NMPA
Etomidate Medium and Long Chain Fat Emulsion Injection
- Product Name
- 依托咪酯中/长链脂肪乳注射液
- Approval Number
- 国药准字H20254019
- Approval Date
- Apr 30, 2025
NMPA
Metformin Hydrochloride Extended-release Tablets
- Product Name
- 盐酸二甲双胍缓释片
- Approval Number
- 国药准字H20253450
- Approval Date
- Feb 25, 2025
NMPA
Ademetionine Butanedisulfonate for Injection
- Product Name
- 注射用丁二磺酸腺苷蛋氨酸
- Approval Number
- 国药准字H20249503
- Approval Date
- Dec 1, 2024
NMPA
Roxatidine Acetate Hydrochloride for Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20249114
- Approval Date
- Oct 22, 2024
NMPA
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20249044
- Approval Date
- Oct 9, 2024
NMPA
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20249022
- Approval Date
- Oct 9, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 32
- Next
Clinical Trials
No trials found
News
No news found